Cytosolix
Tolland, US · Delaware corporation · 3 known investors
Cytosolix uses its Tumor Activated Permeability (TAP) platform to redesign small molecule oncology drugs into weakly-acidic derivatives that exploit tumor acidity to selectively target and accumulate in solid tumors while sparing healthy tissue. Based on research from Yale University, its pipeline includes an androgen receptor inhibitor for early-stage prostate cancer and additional inhibitors for breast and other cancers.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
JD
John DeaconNamed on SEC filing
CJ
Colin J. FosterNamed on SEC filing
D
Deacon
Board
JW
AB
Alex BrunickiBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 1 round · 2023
▶$6.6MraisedJun 2023 · 12 investors · BiotechnologyRule 506(b)
▶$6.6MraisedJun 2023 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason WhitmireDirector
- John DeaconExecutive Officer, Director
- Colin J. FosterExecutive Officer, Director
- Alex BrunickiDirector
- Offering amount
- $6.6M
- Amount sold
- $6.6M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cytosolix do?
- Cytosolix uses its Tumor Activated Permeability (TAP) platform to redesign small molecule oncology drugs into weakly-acidic derivatives that exploit tumor acidity to selectively target and accumulate in solid tumors while sparing healthy tissue. Based on research from Yale University, its pipeline includes an androgen receptor inhibitor for early-stage prostate cancer and additional inhibitors for breast and other cancers.
- Who are Cytosolix's investors?
- Cytosolix's investors include Backed, BlueYard Capital, BY Capital GmbH Co. KG.
- How much funding has Cytosolix raised?
- Cytosolix has disclosed $6.6M raised across 1 round.
- Where is Cytosolix headquartered?
- Cytosolix is headquartered in Tolland, US.